Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2025)

Precision Biosciences (DTIL) has disclosed Liabilities from Discontinued Operations for 4 consecutive years, with 885000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities from Discontinued Operations fell 32.13% to 885000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 885000.0, a 32.13% decrease, with the full-year FY2024 number at 1204000.0, down 52.09% from a year prior.
  • Liabilities from Discontinued Operations was 885000.0 for Q3 2025 at Precision Biosciences, roughly flat from 885000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 2513000.0 in Q4 2023 to a low of 885000.0 in Q1 2025.
  • A 4-year average of 1393333.33 and a median of 1304000.0 in 2024 define the central range for Liabilities from Discontinued Operations.
  • Peak YoY movement for Liabilities from Discontinued Operations: soared 46.36% in 2023, then plummeted 52.09% in 2024.
  • Precision Biosciences' Liabilities from Discontinued Operations stood at 1717000.0 in 2022, then skyrocketed by 46.36% to 2513000.0 in 2023, then tumbled by 52.09% to 1204000.0 in 2024, then dropped by 26.5% to 885000.0 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Liabilities from Discontinued Operations are 885000.0 (Q3 2025), 885000.0 (Q2 2025), and 885000.0 (Q1 2025).